Senarai ini berdasarkan senarai pantauan pengguna Stock Events yang mengikuti TQ8.MU. Ia bukan cadangan pelaburan.
Senarai ini adalah analisis berdasarkan peristiwa pasaran terkini. Ia bukan cadangan pelaburan.
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH1902, which is in Phase 1/Part A clinical trials for the treatment of triple negative breast cancer; and TH1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
Show more...
FAQ
Apakah simbol saham Theratechnologies?▼
Bergantung pada bursa, simbol saham mungkin berbeza. Sebagai contoh, di bursa , saham Theratechnologies didagangkan di bawah simbol TQ8.MU.
Berapa ramai pekerja yang dimiliki oleh Theratechnologies?▼
Sehingga Julai 08, 2026, syarikat mempunyai 103 pekerja.
Theratechnologies terletak dalam sektor apa?▼
Theratechnologies beroperasi dalam sektor Kesihatan & Kesejahteraan.
Bilakah Theratechnologies menyiapkan split saham?▼
Theratechnologies tidak mempunyai sebarang split baru-baru ini.
Di manakah ibu pejabat Theratechnologies?▼
Ibu pejabat Theratechnologies terletak di Montreal, Kanada.